Markets:

Overview

News

Currencies

International

Treasuries

Renalytix plc - American Depositary Shares (NQ:RNLX)

0.2071 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 7, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Renalytix plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 Next >

Stocks That Hit 52-Week Lows On Monday ↗

February 07, 2022

On Monday, 71 stocks hit new 52-week lows. Noteable 52-Week Lows: 3M (NYSE:MMM) was the biggest company in terms of market cap to set a new 52-week low. OceanPal (...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

February 04, 2022

On Friday, 209 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Meta Platforms (NASDAQ:FB) was the largest firm on a market cap...

Via Benzinga

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré ↗

December 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Acadia Announces Positive Phase 3 Data For Trofinetide In Rett Syndrome...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

January 25, 2022

On Tuesday, 88 companies set new 52-week lows. Interesting Highlights From Today's 52-Week Lows: Credit Suisse Group (NYSE:CS) was the largest, in terms of market cap...

Via Benzinga

Earnings Scheduled For December 7, 2021 ↗

December 07, 2021

Companies Reporting Before The Bell • Core & Main (NYSE:CNM) is expected to report quarterly earnings at $0.30 per share on revenue of $1.29 billion. •...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022 ↗

January 18, 2022

Upgrades Canaccord Genuity upgraded the previous rating for Fortuna Silver Mines Inc (NYSE:

Via Benzinga

Now Is The Time To Buy This AI Healthcare Company ↗

December 16, 2021

Let’s take a dive into exactly what is unique about the Renalytix’s technology—and why the company is sitting in the proverbial catbird seat, thanks to demographics.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For January 4, 2022 ↗

January 04, 2022

Upgrades According to Vertical Research, the prior rating for Livent Corp (NYSE:

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 15, 2021

Gainers Statera BioPharma (NASDAQ:STAB) shares rose 16.9% to $3.32 during Friday's regular session. The market value of their outstanding shares is at $91.7 million....

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

September 15, 2021

Gainers Indaptus Therapeutics (NASDAQ:INDP) shares moved upwards by 211.66% to $22.04 during Wednesday's regular session. The market value of their outstanding shares...

Via Benzinga

Earnings Scheduled For October 21, 2021 ↗

October 21, 2021

Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •...

Via Benzinga

46 Biggest Movers From Yesterday ↗

September 15, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) jumped 39.4% to close at $9.41 on Tuesday as the company declared a special dividend of $3.50 per share. Onion Global Limited...

Via Benzinga

36 Stocks Moving In Tuesday's Mid-Day Session ↗

September 14, 2021

Gainers FuelCell Energy, Inc. (NASDAQ: FCEL) shares jumped 26% to $7.08 after the company reported better-than-expected Q3 results. BELLUS Health Inc. (NASDAQ: BLU) shares...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

September 14, 2021

Gainers Progenity (NASDAQ:PROG) stock rose 20.19% to $1.13 during Tuesday's pre-market session. The company's market cap stands at $134.9 million. aTyr Pharma (...

Via Benzinga

20 Stocks Moving in Tuesday's Pre-Market Session ↗

September 14, 2021

Gainers Communications Systems, Inc. (NASDAQ: JCS) rose 34.8% to $9.15 in pre-market trading as the company declared a special dividend of $3.50 per share. DatChat, Inc. (NASDAQ...

Via Benzinga

46 Biggest Movers From Yesterday ↗

August 19, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. SGOCO Group, Ltd. (NASDAQ: SGOC) surged 67...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 18, 2021

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 119.0% to $7.49 during Wednesday's regular session. Trading volume for PharmaCyte Biotech's stock is 144.3...

Via Benzinga

34 Stocks Moving In Wednesday's Mid-Day Session ↗

August 18, 2021

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 139% to $8.18 after surging over 15% on Tuesday. Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) shares surged 58% to $...

Via Benzinga

Mid-Morning Market Update: Markets Mixed; Target Reports Upbeat Profit ↗

August 18, 2021

Following the market opening Wednesday, the Dow traded down 0.12% to 35,300.85 while the NASDAQ rose 0.03% to 14,660.26. The S&P also fell, dropping 0.04% to 4,446.09. The U.S...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

August 18, 2021

Gainers PharmaCyte Biotech (NASDAQ:PMCB) shares rose 71.92% to $5.88 during Wednesday's pre-market session. The market value of their outstanding shares is at $9.4...

Via Benzinga

3 High-Growth Stocks Truly Headed for the Moon ↗

July 16, 2021

Find out why these niche businesses keep growing by leaps and bounds.

Via The Motley Fool

Benzinga's Top Ratings Upgrades, Downgrades For July 2, 2021 ↗

July 02, 2021

Upgrades According to Deutsche Bank, the prior rating for Encompass Health Corp (NYSE:

Via Benzinga

Earnings Scheduled For June 15, 2021 ↗

June 15, 2021

Companies Reporting Before The Bell • Qudian (NYSE:QD) is expected to report quarterly earnings at $0.29 per share on revenue of $95.97 million. • Renalytix AI (...

Via Benzinga

Topics Artificial Intelligence

The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal ↗

May 25, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company...

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 21, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago....

Via Benzinga

The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout ↗

April 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

44 Biggest Movers From Yesterday ↗

April 23, 2021

Gainers KnowBe4, Inc. (NASDAQ: KNBE) shares jumped 50.9% to close at $24.14 on Thursday after the company priced its IPO at $16 per share. Neuropace, Inc. (NASDAQ: NPCE) shares...

Via Benzinga

Topics Initial Public Offering

Mid-Afternoon Market Update: Dow Falls 300 Points; Teradata Shares Spike Higher ↗

April 22, 2021

Toward the end of trading Thursday, the Dow traded down 0.89% to 33,834 while the NASDAQ fell 0.71% to 13,850. The S&P also fell, dropping 0.76% to 4,141.60. The U.S. has the...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 22, 2021

Gainers Renalytix AI (NASDAQ:RNLX) shares rose 21.41% to $30.62 during Thursday's regular session. Renalytix AI's stock is trading at a volume of 1.0 million...

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Renalytix plc - American Depositary Shares (NQ:RNLX)

Headline News about Renalytix plc - American Depositary Shares

Starting at $3.75/week.

Subscribe Today